跳至主要内容
临床试验/NCT01013012
NCT01013012已完成4 期

Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery

Yonsei University0 个研究点目标入组 94 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
94
主要终点
the incidence of postoperative nausea and vomiting(PONV)

研究概览

简要总结

The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Ages 18 to 65 years old

排除标准

  • Patients who is taking steroid or who had been treated for the gastrointestinal disease
  • Patients who have troubles with the kidney or liver
  • Patients transferring to the ICU after the surgery
  • overfat patients
  • Patients who had taken antiemetics within 24 hours before the surgery

研究组 & 干预措施

Group A

Active Comparator

Group A : saline 1 ml + ramosetron 6μg/kg

干预措施: ramosetron with saline (Drug)

Group B

Experimental

Group B : dexamethasone 4 mg + ramosetron 6μg/kg

干预措施: ramosetron with dexamethasone (Drug)

结局指标

主要结局

the incidence of postoperative nausea and vomiting(PONV)

时间窗: After spinal surgery

incidence of overall postoperative nausea and vomiting (PONV) between combination of ramosetron and dexamethasone and ramosetron alone in highly susceptible patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Efficacy of Dexamethasone Added to Ramosetron for... | 临床试验